Adam Rosenberg
About Adam Rosenberg
Adam Rosenberg CEO of Aliada Therapeutics
Adam Rosenberg serves as the CEO of Aliada Therapeutics, bringing over 20 years of industry experience in building healthcare and technology companies. His leadership at Aliada Therapeutics is supported by his extensive background in the biotech sector.
Adam Rosenberg's Role in Other Private Company Boards
In addition to his role at Aliada Therapeutics, Adam Rosenberg serves on the boards of multiple private companies. He is a board member of Sionna Therapeutics and the Chair of Ambagon Therapeutics. His involvement in these companies showcases his commitment to advancing medical and scientific innovations.
Adam Rosenberg's Tenure at Rodin Therapeutics
Adam Rosenberg previously held the positions of President, CEO, and member of the Board of Directors at Rodin Therapeutics. His tenure there culminated in the successful acquisition of the company by Alkermes in 2019, highlighting his ability to lead and grow organizations effectively.
Adam Rosenberg's Venture Partner Experience
Before his current roles, Adam Rosenberg was a Venture Partner at Carnot Pharma under RA Ventures. This experience further underscores his depth of expertise in the pharmaceutical and biotech industries, where he has consistently played pivotal roles in shaping company strategies.
Adam Rosenberg's Contributions as a Co-Founder
Adam Rosenberg co-founded Link Medicine, a company dedicated to developing disease-modifying therapies for neurodegenerative diseases. He also co-founded Teleos Therapeutics, a company focused on innovative neuroscience drug discovery platforms. These ventures reflect his commitment to addressing significant health challenges through innovative therapeutic approaches.
Adam Rosenberg's Board Involvement
Throughout his career, Adam Rosenberg has served as a Director on the boards of multiple venture-backed companies. His board roles across diverse areas, including digital health, materials, and diagnostics, demonstrate his versatile expertise and strategic insight in guiding companies through various stages of growth and development.
Adam Rosenberg's Education Background
Adam Rosenberg earned his Juris Doctor (JD) degree from the University of Virginia School of Law. He also holds a Bachelor of Arts (BA) from Whittier College. His educational background has provided him with a strong foundation in legal and business principles, which he effectively applies in his professional endeavors.
Adam Rosenberg's Role in 'A Late Quartet' Film
Adam Rosenberg extended his advisory and investment expertise to the film industry by contributing to 'A Late Quartet,' a feature film centered on a cellist diagnosed with Parkinson’s disease. This involvement highlights his interest in merging arts with important health narratives.